Should we also evaluate SET together with CIP2A for the...

  • Main
  • 2015 / 08
  • Should we also evaluate SET together with CIP2A for the...

Should we also evaluate SET together with CIP2A for the treatment with second-generation tyrosine kinase inhibitors in chronic myeloid leukemia?

Cristóbal, I, Manso, R, González-Alonso, P, Rojo, F, García-Foncillas, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2015.201
Date:
August, 2015
File:
PDF, 67 KB
english, 2015
Conversion to is in progress
Conversion to is failed